Aurobindo Pharma share news, announcements and annual reports
NSE: AUROPHARMABSE: 524804Pharmaceuticals & BiotechnologyMid Cap
Aurobindo Pharma Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Apr 1995 on BSE, Jul 2000 on NSE
Last close ₹1,683.80up ₹2.40 (0.14%)BSE ₹1,685.00
Share price at the NSE close on 2 Nov 2026. Previous close ₹1,681.40.
2 Nov: open ₹1,688.90, high ₹1,688.90, low ₹1,660.50
52-week range of traded prices to 2 Nov 2026
₹1,106.00Low, 10 Feb 2026₹1,740.00High, 24 Sep 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results and dividend. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹96,882 Cr138th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 26.10
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.56
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 10.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 11.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.20
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 7,38,108
Aurobindo Pharma record dates, bonuses and splits
41 filed, newest first.
Jul 2024
18 Jul · Corporate action
Feb 2024
7 Feb · Corporate action
Nov 2023
2 Nov · Corporate action
Jul 2023
Feb 2023
Jul 2022
May 2022
20 May · Corporate action
Feb 2022
9 Feb · Corporate action
Nov 2021
8 Nov · Corporate action
Aug 2021
13 Aug · Corporate action
Feb 2021
10 Feb · Corporate action
Nov 2020
11 Nov · Corporate action
Aug 2020
Feb 2020
Nov 2019
13 Nov · Corporate action
Feb 2019
Nov 2018
12 Nov · Corporate action
Feb 2018
Nov 2017
May 2017
30 May · Corporate action
Nov 2016
May 2016
Feb 2016
9 Feb · Corporate action
Nov 2015
7 Nov · Corporate action
Aug 2015
17 Aug · Corporate action
Aurobindo Pharma Limited had informed the Exchange that the Register of Members and Share Transfer Books of the Company will be closed from August 25, 2015 to August 27, 2015 (both days inclusive) for the purpose of Annual General Meeting. The Company has now informed the Exchange that aforesaid book closure dates will also be considered to determine the entitlement of the shareholders to the interim dividend of 50% i.e. Re.0.50 (Paise fifty only) per equity share of Re .1/- each on the equity share capital of the Company for the year 2015-16 as approved by the Board on August 12, 2015.(Purpose Revised)
Jul 2015
May 2015
28 May · Corporate action
Company has fixed Record Date as June 9, 2015 for the purpose of Third Interim dividend for the year 2014-15.28 May · Corporate action
Board of Directors of the Company at its meeting held on May 28, 2015, inter alia, has considered and recommended for issue of ONE bonus equity share for every ONE equity share held as on a Record Date to be determined. The Bonus Issue will be subject to the approval of the shareholders at the Extraordinary General Meeting of the Company to be held on July 09, 2015 and other applicable statutory and regulatory approvals, if any.
Feb 2015
5 Feb · Corporate action
Company has fixed Record Date as February 18, 2015 for the purpose of Second Interim Dividend for the year 2014-15.
Aug 2014
5 Aug · Corporate action
Aurobindo Pharma Limited had informed the Exchange that the Company has fixed Book Closure from August 19, 2014 to August 27, 2014 (both days inclusive) for the purpose of Annual General Meeting of the company to be held on August 27, 2014. The Company has now informed the Exchange that the Company has fixed Book Closure from August 19, 2014 to August 27, 2014 for the purpose of Annual general Meeting of the Company & Interim dividend. (purpose revised)
May 2014
31 May · Corporate action
Company has fixed Record Date as June 12, 2014 for the purpose of payment of Second Interim Dividend for the year 2013-14.
Nov 2013
8 Nov · Corporate action
Company has fixed Record Date as November 20, 2013 for the purpose of Interim Dividend 2013-14.
Feb 2013
8 Feb · Corporate action
Company has fixed Record Date as February 20, 2013 for the purpose of payment of interim Dividend 2012-13.
Dec 2010
23 Dec · Corporate action
Company has fixed February 11, 2011 as the record for the purpose of sub-division of shares.
Nov 2010
3 Nov · Corporate action
At the meeting of the Board of Directors of the Company held on November 03, 2010, the Board has approved the Sub-division of equity shares of the face value of Rs. 5/- each in the Company into shares with the face value of Rs. 1/- each. The sub-division would be subject to the approval of the shareholders at the proposed Extraordinary General Meeting and such other approvals as may be necessary.
Oct 2010
29 Oct · Corporate action
Company has fixed November 12, 2010 as the record date for the purpose of ascertaining the eligibility of shareholders for payment of interim Dividend, if any, to be declared by the Board of Directors at its meeting to be held on November 03, 2010.